Immunogenicity and Protective Efficacy against Murine Tuberculosis of a Prime-Boost Regimen with BCG and a DNA Vaccine Expressing ESAT-6 and Ag85A Fusion Protein

Influenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosis

(2010) Florian Krammer et al.   JOURNAL OF VIROLOGICAL METHODS

Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers

(2010) Jaap T. van Dissel et al.   VACCINE

Boosting BCG to protect against TB

(2010) Carine Rouanet et al.   Expert Review of Respiratory Medicine

An Improved Whole-Blood Gamma Interferon Assay Based on the CFP21-MPT64 Fusion Protein

(2009) R. Fu et al.   Clinical and Vaccine Immunology

DNA vaccines against mycobacterial diseases

(2009) Marta Romano et al.   Expert Review of Vaccines

Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine againstMycobacterium tuberculosis

(2009) Qing-min Wang et al.   MICROBIOLOGY AND IMMUNOLOGY

Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigs

(2009) Bappaditya Dey et al.   VACCINE

Immunogenicity of candidate chimeric DNA vaccine against tuberculosis and leishmaniasis

(2009) Ayan Dey et al.   VACCINE

Construction of an encapsulated ESAT-6-based anti-TB DNA vaccine and evaluation of its immunogenic properties

(2008) Olesya Nosareva et al.   BIOLOGICAL CHEMISTRY

The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin

(2008) Yan Liang et al.   VACCINE

Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model

(2007) Xionglin Fan et al.   MICROBIOLOGICAL RESEARCH